Home

Articles from Navitus

Navitus MedicareRx (PDP) Remains Nation’s Highest-Rated PBM-Sponsored PDP EGWP for Tenth Consecutive Year
Navitus, the nation’s first and largest transparent, pass-through pharmacy benefit manager (PBM), announced today that its prescription drug plan Navitus MedicareRx (PDP) maintained a 4.5 out of 5 Part D Star Rating from the Centers for Medicare & Medicaid Services (CMS). This is the highest score in the nation among PBM-sponsored prescription drug plans and marks the tenth consecutive year leading the category.
By Navitus · Via Business Wire · November 5, 2025
Navitus Partners with Corporate Wellbeing Platform, Grokker, to Expand Whole-Person Health Resources
Navitus, the nation’s first and largest transparent, pass-through pharmacy benefit manager (PBM), today announced a partnership with Grokker, an award-winning employee wellbeing engagement solution that empowers users to live healthier, more fulfilling lives. The Grokker offering expands a portfolio of digital health solutions available to Navitus clients and members in support of whole-person health.
By Navitus · Via Business Wire · September 9, 2025
Navitus Partners with Costco Pharmacy to Advance Drug Price Transparency
Navitus, the nation’s first and largest transparent, pass-through pharmacy benefit manager (PBM), announced today that cost-plus pricing will now be available through Costco Pharmacy for prescriptions filled at retail and mail order locations. It will be implemented as available for Navitus clients in all lines of business on January 1, 2026.
By Navitus · Via Business Wire · August 5, 2025
Eighth Annual Navitus Drug Trend Report Reveals How Plan Sponsors Save on Prescription Drugs Amid Rising Costs and Inflation
Navitus, an innovative pharmacy benefit manager (PBM), released its 2023 Drug Trend Report today. The eighth annual report shows a year-over-year trend of 6.8% within the commercial book of business. 29% of Navitus commercial clients paid less for prescription drugs in 2023 than they did the previous year - even with inflation and the growing use of expensive new medications like GLP-1s.
By Navitus · Via Business Wire · July 15, 2024